2003

The ImClone Story: A Hyped Drug, a Tainted Icon It was, in retrospect, a festival of hype emblematic of the […]

Five Hurdles for Biotech The science is hot and the stocks are up. Here’s what’s needed to deliver on the

San DNAgo Thanks to a fruitful partnership of academia and private enterprise, a vibrant biotech industry keeps on replicating itself.

Puncturing The ImClone Hype Could ImClone Systems’ Erbitux be a powerful cancer fighter after all? Maybe. A new study presented